Delivery is the mainstay of therapy for<unk><unk>  in the 37 weeks of gestation or occurrence of any of the following: repeated episodes of severe hypertension (blood<unk> ssure≥ 160/110 mmHg), despite maintenance treatment with 3 classes of antihypertensive agents, progressive thrombocytopenia, progressively abnormal renal or liver enzyme tests, pulmonary edema, abnormal neurological features, stroke, myocardial infarction, HELLP syndrome,<unk> , suspected acute placental abruption or vaginal bleeding in the absence of placenta<unk> via, abnormal fetal testing, fetal death, fetus without expectation for survival at the time of maternal diagnosis (lethal anomaly, extreme<unk> maturity), or persistent reversed end-diastolic flow in the umbilical artery.
Pre-eclampsia surgery
Pre-eclampsia medical therapy
Cardiac disease in pregnancy catheterization
Cardiac disease in pregnancy cardiac ablation
Fetal surgery
Pre-eclampsia laboratory findings
Gestational diabetes medical therapy
Pre-eclampsia risk factors